-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Tenaya Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2020 to Q2 2025.
- Tenaya Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2025 was $799K, a 42.6% decline year-over-year.
- Tenaya Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2025 was $3.37M, a 45.8% decline year-over-year.
- Tenaya Therapeutics, Inc. annual Nonoperating Income (Expense) for 2024 was $4.82M, a 32.2% decline from 2023.
- Tenaya Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $7.11M, a 263% increase from 2022.
- Tenaya Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $1.96M, a 2201% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)